Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
Nicole Trepanowski, MD,
Rebecca M. Yim, BA,
Rachel Wetstone, MPH,
Elizabeth MacDonald, BS,
Sarah Servattalab, MD,
Subin Jacob-George, PA,
John E. Harris, MD, PhD
Affiliations
Nicole Trepanowski, MD
Boston University School of Medicine, Boston, Massachusetts; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
Rebecca M. Yim, BA
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Tulane University School of Medicine, Tulane, Louisiana
Rachel Wetstone, MPH
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Florida International University College of Medicine, Herbert Wertheim College of Medicine, Miami, Florida
Elizabeth MacDonald, BS
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
Sarah Servattalab, MD
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
Subin Jacob-George, PA
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
John E. Harris, MD, PhD
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Correspondence to: John E. Harris, MD, PhD, Department of Dermatology, University of Massachusetts Chan Medical School, 364 Plantation Street, LRB 1010, Worcester, MA 01605.
